Common Contracts
3 similar Securities Purchase Agreement contracts by Mirati Therapeutics, Inc.
EX-10.2 5 a13-11577_1ex10d2.htm EX-10.2 FORM OF SECURITIES PURCHASE AGREEMENT TO: METHYLGENE INC. (the “Corporation”)Securities Purchase Agreement • May 5th, 2020
The undersigned (the “Purchaser”) hereby subscribes for and agrees to purchase the number of units of the Corporation (the “Units”) set forth on the following page at a price of C$0.145 per Unit (the “Subscription Price”). The Purchaser agrees to be bound by the terms and conditions set forth in the attached “Terms and Conditions of Subscription for Common Shares and Warrants of MethylGene Inc.” The Purchaser further agrees, without limitation, that the Corporation may rely upon its representations, warranties and covenants contained in this document. Each Unit purchased will consist of one (1) common share in the capital of the Corporation (a “Common Share”) and thirty one-hundredths (0.30) of a common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each whole Warrant shall be exercisable for a period of five (5) years following the Closing Date (as defined herein) and entitle the holder thereof to acquire one (1) Common Share (a “Warrant Share”) at a p
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2013 • Mirati Therapeutics, Inc.
The undersigned (the “Purchaser”) hereby subscribes for and agrees to purchase (i) the number of units of the Corporation (the “Units”) set forth on the following page at a price of C$0.1243 per Unit (the “Subscription Price”); and (ii) C$[ ] principal amount (the “Debenture Subscription Price”) of unsecured convertible debentures issued by the Corporation (the “Debenture”), convertible into Units at a conversion price equal to the Subscription Price. The Purchaser agrees to be bound by the terms and conditions set forth in the attached “Terms and Conditions of Subscription for Debentures, Common Shares and Warrants of MethylGene Inc.”. The Purchaser further agrees, without limitation, that the Corporation may rely upon its representations, warranties and covenants contained in this document. Each Unit purchased will consist of one (1) common share in the capital of the Corporation (a “Common Share”) and thirty one-hundredths (0.30) of a common share purchase warrant (each whole common
FORM OF SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2013 • Mirati Therapeutics, Inc.
The undersigned (the “Purchaser”) hereby subscribes for and agrees to purchase the number of units of the Corporation (the “Units”) set forth on the following page at a price of C$0.145 per Unit (the “Subscription Price”). The Purchaser agrees to be bound by the terms and conditions set forth in the attached “Terms and Conditions of Subscription for Common Shares and Warrants of MethylGene Inc.” The Purchaser further agrees, without limitation, that the Corporation may rely upon its representations, warranties and covenants contained in this document. Each Unit purchased will consist of one (1) common share in the capital of the Corporation (a “Common Share”) and thirty one-hundredths (0.30) of a common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each whole Warrant shall be exercisable for a period of five (5) years following the Closing Date (as defined herein) and entitle the holder thereof to acquire one (1) Common Share (a “Warrant Share”) at a p
